Pharma's Market
SPECIAL REPORT
MOST SHARED
- Amazon, Viacom Close to Web Video Deal
- Government Bailout Actually Hurt Housing Recovery: Zell
- What the New 401(k) Rules Mean for You
- Morici: Curb Trade Deficit, Rev Up Oil to Engineer More Growth and Jobs
- 6 Stocks Unworthy of Biotech Bull Market
- Goldman's van Praag to Retire End of March: Memo
- Stock Market's Three-Year Rally Has Fed to Thank
- 'Greece Should Default Instantly', Economics Professor Says
- Time Warner Earnings Beat Estimates; Shares Rise
- Stocks on the Move Now: Caesars Entertainment Soars
- Stocks on the Move Now: Caesars Entertainment Soars
- 6 Stocks Unworthy of Biotech Bull Market
- Morici: Curb Trade Deficit, Rev Up Oil to Engineer More Growth and Jobs
- Disney’s Earnings Beat; CEO Bob Iger Talks Piracy, Parks
- Three Phases of the Rally to Watch Out For: Strategist
- Morgan Stanley Bulls Look for More
- Guest Blog: Tax Doesn't Have to Be Taxing
- Top 4 Staffing Stocks for an Improving Economy
- Coke Is a ‘Recession-Proof’ Stock: Analyst
- What Would Happen If the Fed Were Actually Abolished
- Government Bailout Actually Hurt Housing Recovery: Zell
- What the New 401(k) Rules Mean for Your Savings
- Santorum's Three Victories Revive White House Hopes
- Front-Runner Mitt Romney Struggles to Seal the Deal
- New York Housing Market Could Still Collapse: Analyst
- Frustrations Soar as Greeks Seek Elusive Bailout
- 'Greece Should Default Instantly': Economics Professor
- 12 Unique Dating Sites
RSS FEED
Eli Lilly: Will They Get Lucky With 'One A Day' Cialis?
Reporter
![]() |
CNBC.com |
Yeah, I know this will lead to a whole new genre of late-night TV jokes about the nearly 10-year-old erectile dysfunction (ED) drug class. But in all seriousness, urologists (the doctors who specialize in treating ED) say there's a market for a one-a-day.
Dr. Kevin McVary at the Northwestern University School of Medicine, who does consulting and/or works on clinical trials for the ED drugmakers, says there's a "sizeable minority" of patients who would take Cialis every day. He told me that he works with couples who don't like their foreplay interrupted by what can be a mood-killing pause to take an ED drug and then sit around waiting for it to take effect. With a one-a-day version, he says, that worry is gone.
Cialis is the one that lasts 36 hours. And it takes effect faster than Pfizer's [PFE
Loading...
()
] Viagra and Levitra from Bayer, GlaxoSmithKline [GSK
Loading...
()
] and Schering-Plough [SGP
Loading...
()
] . Viagra and Levitra also only last a few hours or so. Sales growth of the ED drugs has slowed, but it's still around a $3-billion-a-year business. Cialis sales, for example, were up 27% in the third quarter.
But here's the rub. A Lilly spokesperson says the FDA has asked for more information on one-a-day Cialis, so a decision on approving it will likely be delayed beyond today. Deutsche Bank's Barbara Ryan is out with a research note to clients this afternoon saying the agency wants "additional analyses of existing data". So, that presumably means Lilly doesn't have to go back to square one and do more tests, it just has to crunch more numbers or something.
But you gotta love Ryan's take on all this: "Once daily dosing could appeal to men with ED who are eternal optimists or have relatively active sexual lives, and we expect it could provide some modest incremental growth to the Cialis franchise." Deutsche owns at least one percent of LLY, makes a market in the stock and has done and wants to do more investment banking for the company.
The Lilly spokesperson told me the drug is intended for men "who anticipate having sex at least twice a week." It's already approved in Europe where Lilly is launching it now. American men will just have to wait.
Questions? Comments?











